Together, these findings support the concept that soluble APP and Aβ oligomers promote synaptic impairment and cognitive deficits during the early stages of AD, followed by neurodegeneration in the later stages (Ferreira and Klein, 2011). This evidence concerns the gene APP and Alzheimer disease.